cancer
-
Health
AI Model REDMOD Detects Early Pancreatic Cancer Signals Years Before Clinical Diagnosis
The landscape of oncology may be on the cusp of a paradigm shift, as a new artificial intelligence framework demonstrates…
Read More » -
Health
Moderna and Merck Cancer Vaccine Success Marks a Historic Turning Point in Oncology
The landscape of cancer therapeutics has undergone a seismic shift following the presentation of pivotal clinical trial data in Madrid,…
Read More » -
Lifestyle
Understanding Scanxiety: The Psychological Toll of Cancer Surveillance and How Patients Cope
When Ali Heitz arrived at the hospital for her one-year post-diagnosis check-up, she expected a routine appointment. Having endured months…
Read More » -
Health
Rising Incidence of Advanced Colorectal Cancer in Young Patients Signals Urgent Need for Diagnostic Vigilance
New research presented at the American Academy of Pediatrics (AAP) 2026 National Conference & Exhibition, held October 2–6, 2026, at…
Read More » -
Health
New Insights Into T Cell Exhaustion Reveal Potential for Enhancing Cancer Immunotherapy Through MEK Inhibition
Cancer immunotherapy represents one of the most significant shifts in oncology over the past two decades, offering hope where traditional…
Read More » -
Health
Oregon State University Researchers Develop Dual-Action Nanoparticle Therapy to Combat Lung Cancer and Muscle Wasting
In a significant breakthrough for oncology and regenerative medicine, a team of researchers at Oregon State University (OSU) has engineered…
Read More » -
Health
New Research Challenges Longstanding Estimates of Overdiagnosis in Breast Cancer Screening
Breast cancer screening has long been viewed as a cornerstone of women’s preventative health, yet it remains a subject of…
Read More » -
Health
Reassessing the Scale of Breast Cancer Overdiagnosis Through a New Lens of Temporal Context and Clinical Evidence
For decades, the medical community has grappled with a fundamental dilemma in oncology: the phenomenon of overdiagnosis in breast cancer…
Read More » -
Health
Breakthrough Experimental Drug CS18 Shows Promise in Overcoming Treatment-Resistant Cancer Cells
Researchers at Baylor College of Medicine have achieved a significant milestone in oncology by developing an experimental compound, CS18, designed…
Read More » -
Health
This new drug could break cancer’s resistance to treatment
The pursuit of durable cancer remission is frequently thwarted by the biological adaptability of malignant tumors. While initial chemotherapy, targeted…
Read More »